Aspergillus flavus myositis in a patient after liver transplantation

Clinical Transplantation

Volumn 22, Issue 4, 2008, Pages 508-511

  Li, Dong Ming ^a,b   Xiu, Dian Rong ^a   Li, Ruo Yu ^a   Samson, R A ^b   De Hoog, G S ^b   Wang, Duan Li ^a  

^a PEKING UNIVERSITY   (China)

^b CBS KNAW FUNGAL BIODIVERSITY CENTRE   (Netherlands)

Author keywords

Aspergillosis; Aspergillus flavus; Liver transplantation; Myositis

Indexed keywords

AMPHOTERICIN; CYCLOSPORIN; FLUCONAZOLE; FLUCYTOSINE; INTERNAL TRANSCRIBED SPACER; ITRACONAZOLE; KETOCONAZOLE; MICONAZOLE; NYSTATIN; PREDNISONE; TERBINAFINE;

ADULT; ANTIFUNGAL RESISTANCE; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; ASPERGILLOSIS; ASPERGILLUS FLAVUS; CASE REPORT; CONIDIUM; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ECHOGRAPHY; FATIGUE; FOLLOW UP; FUNGUS CULTURE; FUNGUS HYPHAE; GASTROCNEMIUS MUSCLE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOCOMPROMISED PATIENT; IMMUNOSUPPRESSIVE TREATMENT; LEG SWELLING; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MINIMUM INHIBITORY CONCENTRATION; MUSCLE BIOPSY; MUSCLE NECROSIS; MUSCLE WEAKNESS; MYALGIA; MYCOSIS; MYOSITIS; NEEDLE BIOPSY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

ADULT; ASPERGILLOSIS; ASPERGILLUS FLAVUS; HUMANS; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MYOSITIS; POSTOPERATIVE COMPLICATIONS; TREATMENT OUTCOME;

EID: 48249151783     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2008.00801.x     Document Type: Article

References (24)

1. Fischer L, Sterneck M. Invasive fungal infections in patients after liver transplantation. Mycoses 2005: 48 (Suppl.1): 27.
2. Fraser JF, Mullany D, Natani S. Aspergillus flavus endocarditis -to prevaricate is to posture. Crit Care Resusc 2006: 8: 46.
3. Marr KA, Carter RA, Crippa F, Wald A, Corey L. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 2002: 34: 909.
4. Warnock DA, Hajjeh RA, Lasker BA. Epidemiology and prevention of invasive aspergillosis. Curr Infect Dis Rep 2001: 3: 507.
5. LatgéJP. Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev 1999: 12: 310.
6. Liu ZW, Zou WL, Zhu XD. Clinical analysis of aspergillosis in orthotopic liver transplant recipients. Zhonghua Gan Zang Bing Za Zhi 2005: 13: 171.
7. Ichiyasu H, Yamamura A, Honda M et al. Successful treatment by voliconazole for pulmonary and adductor magnus muscle aspergillosis induced by immunosuppressive therapy for hypersensitivity pneumonia. Nihon Kokyuki Gakkai Zasshi. 2006: 44: 754.
8. Li DM, Li RY, Wang DL, Ma SQ. In vitro activities of five antifungal agents against pathogenic Exophiala species. Chin Med J 1999: 112: 484 (English).
9. De Hoog GS, Zeng JS, Harrak MJ, Sutton DA. Exophiala xenobiotica sp. nov., an opportunistic black yeast inhabiting environments rich in hydrocarbons. Antonie Van Leeuwenhoek 2006: 90: 257.
10. Kleinschmidt -De Masters BK. Central nervous system aspergillosis: A 20-year retrospective series. Hum Pathol 2002: 33: 116.
11. Zhang QQ, Li L, Zhu M, Zhang CY, Wang JJ. Primary cutaneous aspergillosis due to Aspergillus flavus: A case report. Chin Med J (Engl) 2005: 118: 255.
12. Gave AA, Torres R, Kaplan L. Cryptococcal myositis and vasculitis: An unusual necrotizing soft tissue infection. Surg Infect (Larchmt) 2004: 5: 309.
13. Halverson PB, Lahiri S, Wojno WC, Sulaiman AR. Sporotrichal arthritis presenting as granulomatous myositis. Arthritis Rheum 1985: 28: 1425.
14. Javier RM, Sibilia J, Lugger AS, Natarajan -Ame S, Kuntz JL, Herbrecht R. Fatal Aspergillus fumigatus myositis in an immunocompetent patient. Eur J Clin Microbiol Infect Dis 2001: 20: 810.
15. Mylonakis E, Rich JD, Flanigan T et al. Muscle abscess due to Aspergillus fumigatus in a patient with AIDS. Clin Infect Dis 1996: 23: 1323.
16. Reboli AC, Reilly RF, Jacobson RJ. Aspergillus myositis in a patient with a myelodysplastic syndrome. Mycopathologia 1987: 97: 117.
17. Tsai SH, Peng YJ, Wang NC. Pyomyositis with hepatic and perinephric abscesses caused by Candida albicans in a diabetic nephropathy patient. Am J Med Sci 2006: 331: 292.
18. Vandenbos F, Roger PM, M ondain -Miton V, Burel F, Battaglione -Hofman V, D ellamonica P. Aspergillus fumigatus muscle abscess revealing invasive aspergillosis in a patient with AIDS. Presse Med 1998: 27: 1844.
19. Singh N, Pruett TL, Houston S et al. Invasive aspergillosis in the recipients of liver retransplantation. Liver Transpl 2006: 12: 1205.
20. Howell A, Midturi J, Sierra -Hoffman M. Aspergillus flavus scleritis: successful treatment with voriconazole and caspofungin. Med Mycol 2005: 43: 651.
21. H sueh PR, L au YJ, C huang YC. Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: Surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003. Antimicrob Agents Chemother 2005: 49: 512.
22. Gomez -Lopez A, Garcia -Effron G, Mellado E, Monzon A, Rodriguez -Tudela JL, C uenca -Estrella M. In vitro activities of three licensed antifungal agents against Spanish clinical isolates of Aspergillus spp. Antimicrob Agents Chemother 2003: 47: 3085.
23. Lass -Florl C, Kofler G, Kropshofer G et al. In-vitro testing of susceptibility to amphotericin B is a reliable predictor of clinical outcome in invasive aspergillosis. J Antimicrob Chemother 1998: 42: 497.
24. Mosquera J, Warn PA, Morrissey J, Moore CB, Gil-Lamaignere C, Denning DW. Susceptibility testing of Aspergillus flavus: Inoculum dependence with itraconazole and lack of correlation between susceptibility to amphotericin B in vitro and outcome in vivo. Antimicrob Agents Chemother 2001: 45: 1456.